Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $8.12 Million - $10.3 Million
-59,000 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $5.54 Million - $6.88 Million
42,000 Added 247.06%
59,000 $9.56 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $1.83 Million - $2.31 Million
17,000 New
17,000 $2.3 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $265,775 - $292,586
-2,598 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $190,615 - $255,071
2,598 New
2,598 $255,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Axel Capital Management, LLC Portfolio

Follow Axel Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axel Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axel Capital Management, LLC with notifications on news.